Two Deaths From Liver Failure Linked to Spinal Muscular Atrophy Drug Two Deaths From Liver Failure Linked to Spinal Muscular Atrophy Drug
Two children have died 5-6 weeks after infusion with the gene therapy drug onasemnogene abeparvovec (Zolgensma), a treatment for spinal muscular atrophy, its manufacturer reports.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | Children | Gastroenterology | Gene Therapy | Genetics | Liver | Neurology | Neurosurgery | Spinal Muscular Atrophy | Urology & Nephrology